A Randomised Trial Of Zoledronic Acid For Osteoarthritis Of The Knee
Funder
National Health and Medical Research Council
Funding Amount
$989,238.00
Summary
Osteoarthritis (OA) is the most common form of arthritis and is increasing markedly due to an ageing population. Despite its large disease burden, there are currently no approved disease-modifying drugs available which modify structural progression of OA. The aim of this study is to compare zoledronic acid treatment to placebo on knee structural change and knee pain over two years. It is hypothesised that zoledronic acid will reduce cartilage loss, knee pain, and bone marrow lesion size.
A Randomised Controlled Trial To Evaluate The Effectiveness Of Zoledronate Therapy In Osteonecrosis Of The Hip.
Funder
National Health and Medical Research Council
Funding Amount
$535,441.00
Summary
Osteonecrosis of the hip is an important cause of musculoskeletal disability and finding therapeuticsolutions has proven to be challenging. A wide range of surgical treatments with variable success rates ahve been proposed for the treatment. Non-surgical treatment options are limited and usually result in a poor prognosis. This novel clinical trial research will study the protective value of a bisphosphonate in patients with osteonecrosis of the hip and evaluate the cost-effectiveness.
Improving The Prevention And Outcomes Of Knee And Hip Osteoarthritis
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
Osteoarthritis is a major public health problem. No current treatment slows disease progression with end-stage osteoarthritis treated by joint replacement surgery. This project will identify new approaches for the prevention and treatment of osteoarthritis and the improvement of patients’ outcomes after total joint replacement surgery. The findings will have both public health and clinical impact, informing clinical practice of strategies to improve the prevention and outcomes of osteoarthritis.
Are Large Joint Osteoarthritis And Low Back Pain Metabolic Disorders?
Funder
National Health and Medical Research Council
Funding Amount
$381,972.00
Summary
While osteoarthritis (OA) is considered a “wear and tear” disease, there is evidence that OA may be related to a cluster of metabolic abnormalities including obesity, diabetes mellitus, hypertension and high cholesterol. Similarly, low back pain main be linked to a sedentary lifestyle and metabolic changes. This project will examine the relationship between metabolic derangements and back pain and large joint OA in an attempt to better understand these diseases and develop effective treatments.
Using Magnetic Resonance Imaging (MRI) To Improve Understanding Of Knee Osteoarthritis And Develop Effective Therapeutic Treatments
Funder
National Health and Medical Research Council
Funding Amount
$299,564.00
Summary
Osteoarthritis is the most common form of arthritis and is increasing markedly due to an ageing population. This program of research uses magnetic resonance imaging (MRI) to improve our understanding about knee osteoarthritis. It will examine knee structural change over time using unique 10-year follow-up MRI measures from a pre-existing case-control study. This program of research will also examine two randomised controlled trials which aim to evaluate therapeutic treatments for the disease.